coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Farnworth & Kearsley PCN, Bolton (LAD) · Health Inequalities Profile

    PCN U09883 · NHS Greater Manchester Integrated Care Board · 4 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    37,153

    Registered population

    61.1% aged 18–64

    16.0%

    Aged 65+

    ICB 14.9% · England 17.9%

    18.4%

    Ethnic minority (non-White)

    11.9% Asian · England 9.6%

    70.9%

    In IMD quintile 1

    ICB 40.7% · England 21.0%

    ~25,831

    Core20 residents (est.)

    Resident basis; registered basis ~27,407 · see page 3

    5,933

    Hypertension register

    +3.32% in 3 yrs · England +5.60%

    472

    SMI register

    13% of Bolton (LAD)'s

    1,603

    COPD register

    Reviews -1.19% in 3 yrs

    Forecast to 2030

    6,361

    Hypertension patients, 2030

    +428 on today

    71.0%

    QRISK ≥20% on statins, 2030

    +1.58pp over 3 yrs

    3.4%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    59.3%
    Asthma reviews lag England despite high burden.

    Annual asthma reviews reach 59.3% (vs 65.7% England) across 2,504 patients, leaving a scale gap of 1,019 (about 1,000) without a recorded review.

    26.8 pp
    Practice phone access and vaccination vary sharply.

    Phone contact spans 26.8 pp from 51.1% at Kearsley Medical Centre to 77.9% at Farnworth Family Practice, while QOF vaccination spans 44.4 pp.

    +8.0 pp
    Under-80 blood pressure control outpaced England.

    Blood pressure control under age 80 rose +8.0 pp (England +2.1 pp) to 66.8%, and QRISK ≥ 20% lipid therapy reaches 67.7% (England 63.6%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Children comprise 22.8% and older adults 16.0% across 37,153 registered patients

    Farnworth & Kearsley PCN has 37,153 registered patients. Children aged 0-17 comprise 22.8% (Bolton 23.7%, ICB 21.8%, England 19.6%), while 16.0% (5,951 patients) are aged 65+ (Bolton 14.7%, ICB 14.9%, England 17.9%). Residential Census data shows 81.6% White and 11.9% Asian or Asian British residents, against 72.0% and 20.1% in Bolton, 76.4% and 13.6% in the ICB, and 81.1% and 9.6% nationally. Unadjusted dementia prevalence is 0.7% (273 patients; gap of +6 to +18 against borough and England benchmarks). ONS list growth to 2030 is projected at 0.6% (methodology unverified).

    Age profile

    0–1722.8%
    18–6461.1%
    65+16.0%

    65+: ICB 14.9%, England 17.9%

    Ethnicity

    White81.6%
    Asian11.9%
    Black3.2%
    Mixed2.1%
    Other1.2%

    Older people · falls rows are Bolton (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Bolton LA)1,9232,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)71.6%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)54.8%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Bolton LA)9581,0219552024/25
    Falls deaths, all ages, per 100,000 (Bolton LA)19.018.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 covers 70.9% of registered patients with a sharp 40.7 pp practice spread

    Core20 covers 70.9% of registered patients, exceeding Bolton (LAD) at 47.8%, the ICB at 40.7%, and England at 21.0%. Average IMD decile is 2.7 against 5.5 in England. Practice concentration spans 40.7 pp, from 50.5% at Kearsley Medical Centre to 91.2% at Fig Tree Medical Practice. Absolute volume centres on Stonehill Medical Centre, with an estimated 12,257 Core20 patients. Weighted practice share of 73.8% differs from the PCN figure by 2.85 pp. Outreach planning therefore needs to balance high-concentration practices with high-volume caseloads.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Fig Tree Medical91.2% · 4,586 patients
    Farnworth90.4% · 3,956 patients
    Stonehill83.5% · 12,257 patients
    Kearsley50.5% · 6,608 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    472

    SMI register

    1.27% recorded prevalence

    291

    Learning disability register

    0.78% recorded prevalence

    4

    Care homes, 208 beds

    In the PCN catchment

    9.8%

    Provide unpaid care

    Bolton (LAD), Census 2021

    Recorded prevalence is 1.3% for severe mental illness (472 patients) and 0.8% for learning disabilities (291 patients), exceeding Bolton (1.1% and 0.6%), the ICB (1.1% and 0.6%) and England (1.0% and 0.6%). The catchment includes 4 care homes with 208 beds, though resident registrations are unconfirmed. As SMI and learning disability registers exceed national rates, proactive physical health checks across these cohorts remain an inclusion-health workload to sustain.

    Severe mental illness: physical health checks

    SMI checks trail England: blood pressure recording is 82.6% (England 83.4%; Kearsley Medical Centre 75.3%) and BMI is 80.5% (England 82.1%; Kearsley Medical Centre 67.3%). Individual checks do not establish complete health checks.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    5,933

    Hypertension register

    +3.32%

    Register growth, 3 yrs

    Bolton (LAD) +4.70% · England +5.60%

    +7.95pp

    BP control, under 80

    ≤140/90 · +3.87pp aged 80+

    +428

    More patients by 2030

    Forecast 6,361 (17.05%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 16.0% (5,933 patients), above Bolton (LAD) (14.8%), NHS Greater Manchester Integrated Care Board (14.4%) and England (15.2%). Blood pressure control under 80 improved +8.0 pp over three years (England +2.1 pp) to 66.8%, trailing Bolton (LAD) (67.3%), NHS Greater Manchester Integrated Care Board (68.6%) and England (67.8%), with Kearsley Medical Centre at 64.1%. Patients treated to target rose +7.6 pp over three years to 69.1% (England 70.3%). Denominators include personalised care adjustments. Rapid control gains leave the PCN trailing comparators, suggesting that prioritising recall and blood pressure titration at Kearsley Medical Centre may help close the gap.

    Lipids and statins

    Lipid-lowering therapy for QRISK ≥ 20% reaches 67.7%, exceeding Bolton (LAD) (63.0%), NHS Greater Manchester Integrated Care Board (67.0%) and England (63.6%), though three-year growth (+2.4%) trailed England (+6.2%). Higher coverage indicates sound primary prevention reach, while slower growth suggests audits could focus on sustaining high-risk review.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202670,842£1.90£1.94£1.86£134,600
    Cardiovascular (all), 202595,626£3.49£3.15£3.33£333,735

    For lipid-regulating drugs in 2026, the PCN prescribed 70,842 items at £1.90 per item (Bolton (LAD) £1.81, NHS Greater Manchester Integrated Care Board £1.94, England £1.86), spending £2,834 more than at England's unit cost. Unit cost does not measure prescribing efficiency, but reviewing formulary choices could help optimise expenditure.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +4.41%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −0.06%

    Asthma prevalence, PCN 3-yr % change

    COPD prevalence is 4.3% (1,603 patients; +42.0% over three years vs +2.6% England) and asthma is 7.2% (2,504 patients vs 6.6% England), with child asthma prescribing at 2,903 per 1,000 (vs 1,488 England). However, 12-month reviews lag England for COPD (70.6% vs 76.4%) and asthma (59.3% vs 65.7%; a gap of about 1,000 patients), while child second-hand smoke recording is 69.0% (vs 78.8% England). High disease burden alongside lagging reviews suggests review recall and smoke recording warrant prioritisation.

    Cancer register and children's immunisation

    The cancer register records 1,150 patients (3.1% vs 3.8% England; +5.2% over three years vs +9.0% England). While 12-month 6-in-1 uptake is 95.6% (vs 91.0% England), age-5 MMR2 coverage is 83.8%, falling below the 95.0% target by 11.2 pp with a 5.7 pp gap from same-cohort MMR1 (89.5%). Strong infant completion contrasts with lower pre-school booster uptake, suggesting potential for targeted pre-school recall.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months95.6%

    England 91.0%

    6-in-1 complete primary course at 24 months94.2%

    England 92.2%

    MMR dose 1 at 24 months92.8%

    England 88.3%

    MMR dose 2 at age 583.8%

    England 82.8%

    4-in-1 pre-school booster at age 582.9%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Greater Manchester ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,270

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Greater Manchester ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%15%2,193
    Prostate61.7%53.2%14%1,788
    Breast82.5%85.4%19%1,758
    Bowel46.3%47.0%19%1,427
    Skin cancer84.5%87.8%27%580

    Across NHS Greater Manchester ICB in 2022, 55.6% of cancers with a known stage (6,491 of 11,679) were diagnosed at stage 1 or 2, compared with 55.3% in England, showing a distance of -19.4 pp to the 75.0% national ambition by 2028. Closing that gap represents about 2,270 additional early-stage cases across the ICB. Known-stage coverage was 70.8% (11,679 of 16,492; England 67.0%), while bowel (46.3%) and lung (40.4%) trailed breast (82.5%). Small cohorts such as anus (29 of 57) warrant caution. Staging reflects system pathways rather than PCN performance; locally, cervical screening was 67.0% with a three-year change of -2.0%.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    At Bolton NHS Foundation Trust in July 2026, 62-day cancer treatment reached 69.7%, trailing the 85.0% standard by 15.3 pp, below Manchester University NHS Foundation Trust (72.8%), Northern Care Alliance NHS Foundation Trust (78.6%), NHS Greater Manchester Integrated Care Board (75.7%) and England (71.2%). Conversely, the 28-day faster diagnosis standard reached 80.5% (standard 75.0%), exceeding Northern Care Alliance NHS Foundation Trust (75.2%), the ICB (79.5%) and England (79.3%). In diagnostics, Bolton's 6-week waits reached 19.4% for computed tomography (England 9.9%) and 25.3% for cystoscopy, while colonoscopy was 1.3% against 30.8% across England.

    Pathways within standard (%)BoltonNorthern Care AllianceManchesterGreater Manchester ICBEngland
    28-day faster diagnosis (75%)80.4875.2080.0679.5379.32
    31-day treatment (96%)96.5094.5492.5496.4992.50
    62-day referral to treatment (85%)69.6678.6572.8575.7371.16
    Diagnostic waits over 6 weeks (%)BoltonNorthern Care AllianceManchesterEngland
    MRI2.055.0911.6821.40
    CT19.404.1014.669.92
    Echocardiography3.4831.484.9128.48
    Colonoscopy1.3340.044.5130.83
    Gastroscopy2.0636.4829.3529.02
    All 15 DM01 tests15.7815.718.9823.14
    Community services activityBolton residentsGreater Manchester ICB
    Care contacts49,315573,310
    Referrals4,07594,470
    Patients with a contact17,765183,535

    Community services (residents of Bolton), Jun 2026 (provisional). In June 2026, community health service contacts for Bolton residents totaled 49,315, with adults aged 65 and over accounting for 25,460 contacts, or 51.6% of all recorded activity. These figures reflect borough-wide resident service usage rather than PCN-specific delivery, indicating older-age community health service use across the local authority footprint.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice vaccination achievement spans 44.4 pp and phone access varies by 26.8 pp

    QOF vaccination achievement spans 44.4 pp, from 26.3% at Stonehill Medical Centre to 70.7% at Farnworth Family Practice (England 55.2%). While Stonehill Medical Centre reached 100.0% in the clinical domain, its all-domain personalised care adjustment rate reached 14.0% (England 10.0%). Kearsley Medical Centre recorded 81.4% overall QOF achievement against England's 92.5%.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Farnworth11790.477.9%84.3%88.7%
    Kearsley12450.551.1%76.9%78.3%
    Stonehill10983.555.8%81.7%73.7%
    Fig Tree Medical10091.276.0%69.7%72.2%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNBolton (LAD)AssetPCNBolton (LAD)
    Care homes (catchment)4 (208 beds)n/aSchools (catchment)36n/a
    Children's centres318Places of worship20144
    Librariesn/a7Primary schools (LA maintained)1161
    Primary academies432Special schoolsn/a3

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured respiratory and asthma review recall

    Asthma reviews reach 59.3% (vs 65.7% England; scale gap 1,019, about 1,000 of 2,504 patients) and COPD reviews reach 70.6% (vs 76.4% England across 1,603 patients). For discussion: the PCN could run single-template asthma and COPD recall, adding after-school slots and second-hand smoke recording (69.0% vs 78.8% England). Moderate effort to run.

    Evidence base: the copd register is the cohort for spirometry-confirmed diagnosis, annual review and inhaler technique; register size and growth set the workload those interventions must cover.

    Policy anchor: Core20PLUS5 adults: chronic respiratory disease (COPD vaccination and exacerbation reduction); Tobacco and Vapes Bill: smokefree generation.

    Option 2

    Dementia coding and case-finding audit

    Recorded dementia prevalence is 0.7% (273 of 37,153 patients vs 0.7% Bolton (LAD) and 0.8% England; 3-year change +4.7% vs +6.0% England), giving an unadjusted benchmark range of +6 to +18. Low cost, quick to run.

    Evidence base: dementia diagnosis rates lag in deprived and minority ethnic populations and in care homes; the register is the cohort for diagnosis-rate improvement and the annual dementia review, and diagnosis and post-diagnostic support delay care-home entry.

    Policy anchor: national dementia diagnosis-rate ambition of 66.7%; 95% of people with complex needs to have an agreed care plan by 2027.

    Option 3

    SMI health checks and access review

    Across 472 SMI patients (1.3% vs 1.0% England), BMI recording is 80.5% (England 82.1%; Kearsley Medical Centre 67.3%), BP is 82.6% (Kearsley Medical Centre 75.3%), and psychosis alcohol recording fell 4.5 pp (England +5.4 pp) to 73.9%. Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Older adult dementia register review (p2)Dementia: QOF prevalence66.7% diagnosis ambition · 95% care plan 2027PCN
    Two-track Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical check recall (p4)SMI register with a BMI recorded in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension blood pressure control review (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster recall (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Telephony and triage capacity review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Structured respiratory and asthma review recall (p12)COPD register · COPD: QOF prevalence · Asthma registerCore20PLUS5 respiratoryPCN
    Option 2 · Dementia coding and case-finding audit (p12)Dementia register · Dementia: QOF prevalence · Aged 65+66.7% diagnosis ambition · 95% care plan 2027PCN
    Option 3 · SMI health checks and access review (p12)Severe mental illness register · Severe mental illness: QOF prevalence · SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN & Practice
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15